Answers are grounded in this paper and cite their sources.
To estimate the prevalence and study the clinical presentation of mild cognitive impairment (MCI), assess its outcome in terms of cognition and quality of life, identify factors for reversion to baseline, and compare these factors in the modifiable and nonmodifiable risk factor groups.
No takes yet. Share an insight, caveat, or question.
Moria et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: